Investor Presentation - Winter/Spring 2024
THE DIGITAL PLATFORM FOR DOCTORS
Leading Network
Blue Chip Clients
Growth and Profit
80%+ 20/20
of all U.S.
Physicians¹
Top Hospitals
and Health Systems
Top Pharmaceutical
Manufacturers³
18%
Subscription
Revenue Growth4
>560K 115% 48%
Workflow Unique
Active Providers²
Net Revenue
Retention Rate4
Adj. EBITDA
Margin
1. As of 12/31/23.
2. For fiscal quarter ending 12/31/23.
3. Top 20 Pharmaceutical Manufacturers based on data from Evaluate, Top 20 hospitals based on U.S. News & World Report's Best Hospitals U.S. News Best Hospitals 2023-2024 Honor Roll.
4. For the trailing twelve month (TTM) period ending 12/31/23. Refer to appendix for definitions and non-GAAP reconciliations.
doximity
A
STAT
9:47
d
The Now England Journal of Medicine
The Interview Trial: Bias Has a Now Face
read
As a tense plicant, interviewing for residency
training has provided a personal baromete ning
Investor Presentation - February, 2024View entire presentation